<p>(A) CFSE-labelled CD4<sup>+</sup> OTII T cells were used as responder and stimulated with OTII<sup>323–339</sup> peptide in the presence of DCs. Either CD8<sup>+</sup>CD38<sup>high</sup> (CD38<sup>high</sup>) or CD8<sup>+</sup>CD38<sup>−</sup> (CD38<sup>−</sup>) T cells were added to the culture at different CD8:CD4 ratios. Histograms show the CFSE dilution of the CD4<sup>+</sup> OTII T cells after three days of culture (gated on CD4<sup>+</sup> T cells). Numbers represent the percentage of proliferating cells. Proliferation of CD4<sup>+</sup> T cells incubated with DC only, or in addition with OTII<sup>323–339</sup> peptide are shown as a negative (neg ctrl) and positive control (pos ctrl), respectively. One of at least four independent...
<p>(A) OVA(257-264) peptide-pulsed or unpulsed DCs were cultured with OT-I transgenic CD8<sup>+</sup...
<p>Heatkilled BCG-activated and live BCG-activated T cell lines were expanded, and live BCG T-cell l...
<p>(A) Protocol for the induction of cancer antigen-specific CD8<sup>+</sup> T cells by CD14-ML-DC. ...
<p>1×10<sup>5</sup> CD4<sup>+</sup> OTII T cells were stimulated with (pos ctrl) or without (neg ctr...
<p>CD4 T cells were labeled with CFSE and co-cultured with CD8 Treg cells in different ratios (1∶1, ...
<p>(a) Flow cytometry results. The control was normal spleen lymphocytes. The N<sub>71–78</sub> grou...
<p>Purified CD4<sup>+</sup>CD8α<sup>+</sup> or CD4<sup>+</sup>CD8α<sup>−</sup> T cells were co-cultu...
<p>CD8 T-cell populations were sorted on the basis of 2B4, PD-1 and CD160 expression, labeled with C...
<p>BMDCs were left untreated, incubated with LPS (100 ng/ml) alone or in combination with 10 ng/ml o...
<p><b>(A)</b> Representative staining of one volunteer and <b>(B-C)</b> the frequencies of CD45RA<su...
<p>(A) Detection of Treg suppression for CD8<sup>+</sup> T cells. CFSE-labeled CD8<sup>+</sup> T cel...
<p>(a) CFSE-labeled cells (Bulk PBMCs and CD8<sup>+</sup>-depleted PBMCs) were pretreated with anti-...
<p>(A) To study whether co-transfer of CD8 would also improve the peptide sensitivity of CD4<sup>+</...
<p><b>A, B</b>: CFSE-labeled responder cells from control (Control, n = 5–7) and type 1 diabetes (T1...
<p>(<b>A</b>) CD8<sup>+</sup> T cells were stimulated twice by aAPC/mOKT3 with or without CD4<sup>+<...
<p>(A) OVA(257-264) peptide-pulsed or unpulsed DCs were cultured with OT-I transgenic CD8<sup>+</sup...
<p>Heatkilled BCG-activated and live BCG-activated T cell lines were expanded, and live BCG T-cell l...
<p>(A) Protocol for the induction of cancer antigen-specific CD8<sup>+</sup> T cells by CD14-ML-DC. ...
<p>1×10<sup>5</sup> CD4<sup>+</sup> OTII T cells were stimulated with (pos ctrl) or without (neg ctr...
<p>CD4 T cells were labeled with CFSE and co-cultured with CD8 Treg cells in different ratios (1∶1, ...
<p>(a) Flow cytometry results. The control was normal spleen lymphocytes. The N<sub>71–78</sub> grou...
<p>Purified CD4<sup>+</sup>CD8α<sup>+</sup> or CD4<sup>+</sup>CD8α<sup>−</sup> T cells were co-cultu...
<p>CD8 T-cell populations were sorted on the basis of 2B4, PD-1 and CD160 expression, labeled with C...
<p>BMDCs were left untreated, incubated with LPS (100 ng/ml) alone or in combination with 10 ng/ml o...
<p><b>(A)</b> Representative staining of one volunteer and <b>(B-C)</b> the frequencies of CD45RA<su...
<p>(A) Detection of Treg suppression for CD8<sup>+</sup> T cells. CFSE-labeled CD8<sup>+</sup> T cel...
<p>(a) CFSE-labeled cells (Bulk PBMCs and CD8<sup>+</sup>-depleted PBMCs) were pretreated with anti-...
<p>(A) To study whether co-transfer of CD8 would also improve the peptide sensitivity of CD4<sup>+</...
<p><b>A, B</b>: CFSE-labeled responder cells from control (Control, n = 5–7) and type 1 diabetes (T1...
<p>(<b>A</b>) CD8<sup>+</sup> T cells were stimulated twice by aAPC/mOKT3 with or without CD4<sup>+<...
<p>(A) OVA(257-264) peptide-pulsed or unpulsed DCs were cultured with OT-I transgenic CD8<sup>+</sup...
<p>Heatkilled BCG-activated and live BCG-activated T cell lines were expanded, and live BCG T-cell l...
<p>(A) Protocol for the induction of cancer antigen-specific CD8<sup>+</sup> T cells by CD14-ML-DC. ...